Newsfiscal.ai
MIRA Pharmaceuticals Reports Positive Preclinical Results for MIRA-55 in Chronic Inflammatory Pain Model
· Published
Article summary
MIRA Pharmaceuticals announced that its oral drug candidate MIRA-55 demonstrated sustained pain relief comparable to Celebrex in a chronic inflammatory pain study.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…